ProCE Banner Activity

Management of Patients with Newly Diagnosed CLL/SLL


Download these slides from a live symposium at ASCO 2023 to gain more insights into the management of patients with newly diagnosed CLL/SLL

Released: June 02, 2023



Farrukh Awan

Farrukh Awan, MD

Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Division of Hematology/Oncology
Harold C. Simmons Compreshensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

Provided by

Provided by the National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from AstraZeneca, BeiGene Ltd, and Lilly. Supported by independent educational grants from Merck & Co., Inc., Rahway, NJ, USA, and Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.


BeiGene Ltd

Janssen Biotech, Inc.


Merck Sharp & Dohme Corp.

Pharmacyclics LLC, an AbbVie Company


Clinical Care Options, LLC

ProCE Banner